391 related articles for article (PubMed ID: 18684744)
21. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
Ledwich LJ; Clarke K
J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
[TBL] [Abstract][Full Text] [Related]
22. The use of glucocorticoids by rheumatologic patients before attending a specialized department in México.
Alvarez-Hernández E; Vázquez-Mellado J; Casasola-Vargas JC; Moctezuma-Ríos JF; García-García C; Medrano-Ramírez G; Lino-Pérez L; Servín A; Codina H; Burgos-Vargas R
J Clin Rheumatol; 2008 Jun; 14(3):148-52. PubMed ID: 18525433
[TBL] [Abstract][Full Text] [Related]
23. [Frequency of side effects of glucocorticoid therapy in relation to the regimen for administering the hormonal preparations].
Zaremba EF
Vrach Delo; 1984 Nov; (11):60-3. PubMed ID: 6396947
[No Abstract] [Full Text] [Related]
24. Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
Erdurmus M; Cohen EJ; Yildiz EH; Hammersmith KM; Laibson PR; Varssano D; Rapuano CJ
Cornea; 2009 Aug; 28(7):759-64. PubMed ID: 19574912
[TBL] [Abstract][Full Text] [Related]
25. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
Pavelka K; Jarosová K; Suchý D; Senolt L; Chroust K; Dusek L; Vencovský J
Ann Rheum Dis; 2009 Aug; 68(8):1285-9. PubMed ID: 19351624
[TBL] [Abstract][Full Text] [Related]
26. Revisiting the toxicity of low-dose glucocorticoids: risks and fears.
Da Silva JA; Jacobs JW; Bijlsma JW
Ann N Y Acad Sci; 2006 Jun; 1069():275-88. PubMed ID: 16855155
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of glucocorticoid-induced osteoporosis.
Civitelli R; Ziambaras K
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):2-6. PubMed ID: 18791344
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
29. Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Geborek P; Saxne T
Rheumatology (Oxford); 2009 Mar; 48(3):243-5. PubMed ID: 19106164
[TBL] [Abstract][Full Text] [Related]
30. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
[TBL] [Abstract][Full Text] [Related]
31. [When and how to withdraw glucocorticoid therapy in elderly?].
Ardigo S; Genevay S; Vischer U
Rev Med Suisse; 2008 Nov; 4(178):2374-8, 2380-1. PubMed ID: 19051623
[TBL] [Abstract][Full Text] [Related]
32. Problems related to systemic glucocorticoid therapy in children.
Melo-Gomes JA
J Rheumatol Suppl; 1993 Apr; 37():35-9. PubMed ID: 8501750
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
Burge DJ; Bookbinder SA; Kivitz AJ; Fleischmann RM; Shu C; Bannink J
Clin Ther; 2008 Oct; 30(10):1806-16. PubMed ID: 19014836
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
35. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
36. [Intravenously administered high-dose glucocorticosteroids in active rheumatoid arthritis].
Jacobs JW; Weusten BL; Bijlsma JW
Ned Tijdschr Geneeskd; 1995 Jul; 139(27):1370-6. PubMed ID: 7617059
[No Abstract] [Full Text] [Related]
37. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
38. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
39. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
40. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
